Eli Lilly stock's performance is being compared to that of the S&P 500, with some outlets suggesting it may be underperforming. However, there are also indications that the stock may have upside potential and could be a worthwhile investment. The overall state of the stock's performance relative to the market is unclear, with conflicting reports and analyses being presented.